SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-076682
Filing Date
2023-03-22
Accepted
2023-03-22 16:06:32
Documents
16
Period of Report
2023-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d680885d8k.htm   iXBRL 8-K 26012
2 EX-99.1 d680885dex991.htm EX-99.1 85891
3 EX-99.2 d680885dex992.htm EX-99.2 5000
7 GRAPHIC g680885g0322092029744.jpg GRAPHIC 3211
8 GRAPHIC g680885g0322092029931.jpg GRAPHIC 631
  Complete submission text file 0001193125-23-076682.txt   262960

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20230316.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20230316_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20230316_pre.xml EX-101.PRE 11255
10 EXTRACTED XBRL INSTANCE DOCUMENT d680885d8k_htm.xml XML 3357
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 23752973
SIC: 2834 Pharmaceutical Preparations